ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4819ometendo-4819Research ArticleСтатьиArticlesСахарный диабет и консолидация переломовDiabetes and consolidation of fracturesYalochkinaT O

врач

tatiana540@mail.ruPigarovaE A

к.м.н., с.н.с. отделения нейроэндокринологии и остеопатий

-201315062013102№2 (2013)1921Copyright © Yalochkina T.O., Pigarova E.A., 20132013Yalochkina T.O., Pigarova E.A.Yalochkina T.O., Pigarova E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4819

Одним из осложнений сахарного диабета у человека служит неадекватное формирование костной ткани, приводящее к остеопении и нарушению консолидации переломов. В основе этих патологических процессов лежит нарушение регенерации костной ткани в условиях дефицита инсулина и гипергликемии, механизмы которых освещаются в данном мини-обзоре литературы. Имеющиеся в литературе данные свидетельствуют о необходимости тщательного контроля уровня сахара крови и адекватной заместительной терапии для предотвращения костных осложнений сахарного диабета.

One of the complications of diabetes in humans is inadequate bone formation resulting in osteopenia and slow consolidation of fractures. The basis of these pathological processes is a disruption of the regeneration of bone tissue in insulin deficiency and hyperglycemia, the mechanisms of which are highlighted in this mini-review. The published data indicate the need for careful monitoring of blood glucose levels and adequate replacement therapy for the prevention of skeletal complications of diabetes.

сахарный диабетпереломыостеопорозостеопротегеринвитамин Dинсулингипергликемиякостная резорбцияRANK/RANKLdiabetesfracturesosteoporosisRANK/RANKLosteoprotegerinvitamin Dinsulinhyperglycemiabone resorptionReferencesBruhn-Olszewska B., Korzon-Burakowska A., Gabig-Cimińska M. et al. Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol. 2012;59(4):507-13. Epub 2012 Dec 18.Bruhn-Olszewska B., Korzon-Burakowska A., Gabig-Cimińska M. et al. Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol. 2012;59(4):507-13. Epub 2012 Dec 18.De Amorim F.P., Ornelas S.S., Diniz S.F., Batista A.C., da Silva T.A. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats J Mol Histol. 2008; 39: 401–408.De Amorim F.P., Ornelas S.S., Diniz S.F., Batista A.C., da Silva T.A. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats J Mol Histol. 2008; 39: 401–408.Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007 Sep;22(9):1317-28.Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007 Sep;22(9):1317-28.Kagel E.M., Einhorn T.A. Alterations of fracture healing in the diabetic condition. Iowa Orthop J. 1996; 16: 147–152.Kagel E.M., Einhorn T.A. Alterations of fracture healing in the diabetic condition. Iowa Orthop J. 1996; 16: 147–152.Lu H., Kraut D., Gerstenfeld L.C., Graves D.T. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2003; 144: 346–352.Lu H., Kraut D., Gerstenfeld L.C., Graves D.T. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2003; 144: 346–352.Marsell R., Einhorn Т.A. The biology of fracture healing. Injury. 2011 June; 42(6): 551–555.Marsell R., Einhorn Т.A. The biology of fracture healing. Injury. 2011 June; 42(6): 551–555.McNair P., Madsbad S., Christensen M.S. et al. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol. 1979; 90:463–472.McNair P., Madsbad S., Christensen M.S. et al. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol. 1979; 90:463–472.Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008 Aug;23(8):1334-42. doi: 10.1359/jbmr.080323.Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008 Aug;23(8):1334-42. doi: 10.1359/jbmr.080323.Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes — a metaanalysis. Osteoporos Int. 2007; 18: 427–444.Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes — a metaanalysis. Osteoporos Int. 2007; 18: 427–444.Wei W, Wan Y. Thiazolidinediones on PPARγ: The Roles in Bone Remodeling. PPAR Res. 2011;2011:867180. doi: 10.1155/2011/867180. Epub 2011 Oct 29.Wei W, Wan Y. Thiazolidinediones on PPARγ: The Roles in Bone Remodeling. PPAR Res. 2011;2011:867180. doi: 10.1155/2011/867180. Epub 2011 Oct 29.

The authors declare that there are no conflicts of interest present.